The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

Giovam Battista Rini, Manfredi Rizzo, Kaspar Berneis, Ali A. Rizvi

Risultato della ricerca: Article › peer review

23 Citazioni (Scopus)

Lingua originale	English
pagine (da-a)	1-11
Numero di pagine	11
Rivista	Acta Diabetologica
Volume	46
Stato di pubblicazione	Published - 2009

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2724???
???subjectarea.asjc.1300.1310???
???subjectarea.asjc.2700.2712???

Altri file e collegamenti

OA Link

Cita questo

@article{5d7e8cd675764d6a8e8e301783f28093,

title = "The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?",

keywords = "metabolic syndrome",

author = "Rini, {Giovam Battista} and Manfredi Rizzo and Kaspar Berneis and Rizvi, {Ali A.}",

year = "2009",

language = "English",

volume = "46",

pages = "1--11",

journal = "Acta Diabetologica",

issn = "0940-5429",

publisher = "Springer-Verlag Italia",

}

TY - JOUR

T1 - The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

AU - Rini, Giovam Battista

AU - Rizzo, Manfredi

AU - Berneis, Kaspar

AU - Rizvi, Ali A.

PY - 2009

Y1 - 2009

KW - metabolic syndrome

UR - http://hdl.handle.net/10447/36380

M3 - Article

SN - 0940-5429

VL - 46

SP - 1

EP - 11

JO - Acta Diabetologica

JF - Acta Diabetologica

ER -